GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » PB Ratio

Solvonis Therapeutics (LSE:SVNS) PB Ratio : (As of Apr. 08, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Solvonis Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-08), Solvonis Therapeutics's share price is £0.00165. Solvonis Therapeutics's Book Value per Share for the quarter that ended in Sep. 2024 was £0.00. Hence, Solvonis Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Solvonis Therapeutics's PB Ratio or its related term are showing as below:

LSE:SVNS' s PB Ratio Range Over the Past 10 Years
Min: 0.06   Med: 0.53   Max: 18.33
Current: 0.13

During the past 6 years, Solvonis Therapeutics's highest PB Ratio was 18.33. The lowest was 0.06. And the median was 0.53.

LSE:SVNS's PB Ratio is ranked better than
99.66% of 2924 companies
in the Industrial Products industry
Industry Median: 1.83 vs LSE:SVNS: 0.13

During the past 12 months, Solvonis Therapeutics's average Book Value Per Share Growth Rate was -60.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -0.40% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Solvonis Therapeutics was 26.00% per year. The lowest was -24.60% per year. And the median was 5.90% per year.

Back to Basics: PB Ratio


Solvonis Therapeutics PB Ratio Historical Data

The historical data trend for Solvonis Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solvonis Therapeutics PB Ratio Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - - - 3.16 0.30

Solvonis Therapeutics Quarterly Data
May18 May19 May20 May21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 - 0.30 0.33 -

Competitive Comparison of Solvonis Therapeutics's PB Ratio

For the Specialty Industrial Machinery subindustry, Solvonis Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solvonis Therapeutics's PB Ratio Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Solvonis Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Solvonis Therapeutics's PB Ratio falls into.


;
;

Solvonis Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Solvonis Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=0.00165/0.001
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Solvonis Therapeutics  (LSE:SVNS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Solvonis Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Solvonis Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Solvonis Therapeutics Business Description

Traded in Other Exchanges
Address
Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.

Solvonis Therapeutics Headlines

No Headlines